Lymphastat Liquid
Product Images NDC 44911-0614

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Lymphastat (NDC 44911-0614). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Energique, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lymphastat (Enrg161 Lymphastat 2oz 4 8 21)

Lymphastat (Enrg161 Lymphastat 2oz 4 8 21)
This is a warning label for a homeopathic remedy called Lymphastat. It warns pregnant or breastfeeding women to consult a health professional before use and advises to keep the remedy out of reach of children. In the case of an overdose, medical help or poison control should be contacted right away. The label cautions against using the remedy if the tamper-evident seal is broken or missing, and advises that the remedy has not been evaluated by the FDA. A severe or persistent sore throat could be a sign of a serious condition and may require consulting a doctor. The remedy is manufactured by Energique, Inc. and is indicated for temporarily relieving symptoms associated with viral and bacterial infections, such as fever, irritated throat, and cough. It provides directions for administration in adults and children and lists the active and inactive ingredients.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.